Amedisys, Inc. (AMED)
NASDAQ: AMED · IEX Real-Time Price · USD
97.60
-0.13 (-0.13%)
At close: Jul 19, 2024, 4:00 PM
97.52
-0.08 (-0.08%)
Pre-market: Jul 20, 2024, 9:29 AM EDT
Amedisys Employees
Amedisys had 19,000 employees as of December 31, 2023. The number of employees decreased by 1,000 or -5.00% compared to the previous year.
Employees
19,000
Change (1Y)
-1,000
Growth (1Y)
-5.00%
Revenue / Employee
$118,495
Profits / Employee
-$1,084
Market Cap
3.19B
Employees Chart
Employees History
Date | Employees | Change | Growth |
---|---|---|---|
Dec 31, 2023 | 19,000 | -1,000 | -5.00% |
Dec 31, 2022 | 20,000 | -1,000 | -4.76% |
Dec 31, 2021 | 21,000 | 0 | - |
Dec 31, 2020 | 21,000 | -300 | -1.41% |
Dec 31, 2019 | 21,300 | 300 | 1.43% |
Dec 31, 2018 | 21,000 | 3,100 | 17.32% |
Dec 31, 2017 | 17,900 | 1,900 | 11.88% |
Dec 31, 2016 | 16,000 | -100 | -0.62% |
Dec 31, 2015 | 16,100 | 2,900 | 21.97% |
Dec 31, 2014 | 13,200 | -1,100 | -7.69% |
Dec 31, 2013 | 14,300 | -900 | -5.92% |
Dec 31, 2012 | 15,200 | -1,300 | -7.88% |
Dec 31, 2011 | 16,500 | 200 | 1.23% |
Dec 31, 2010 | 16,300 | -400 | -2.40% |
Dec 31, 2009 | 16,700 | 1,900 | 12.84% |
Dec 31, 2008 | 14,800 | 5,900 | 66.29% |
Dec 31, 2007 | 8,900 | 2,008 | 29.14% |
Dec 31, 2006 | 6,892 | 2,611 | 60.99% |
Dec 31, 2005 | 4,281 | 1,747 | 68.94% |
Dec 31, 2004 | 2,534 | 905 | 55.56% |
Dec 31, 2003 | 1,629 | 122 | 8.10% |
Dec 31, 2002 | 1,507 | -14 | -0.92% |
Dec 31, 2001 | 1,521 | 421 | 38.27% |
Dec 31, 2000 | 1,100 | -127 | -10.35% |
Dec 31, 1999 | 1,227 | -327 | -21.04% |
Dec 31, 1998 | 1,554 | 889 | 133.68% |
Dec 31, 1997 | 665 | 200 | 43.01% |
Dec 31, 1996 | 465 | - | - |
Sources: Annual number of employees according to filings submitted to the U.S. Securities and Exchange Commission (SEC). Data is also manually gathered from company press releases, IPO filings, and other official sources.
Related Stocks
Company Name | Employees |
---|---|
iRhythm Technologies | 2,000 |
HUTCHMED (China) | 1,988 |
Inari Medical | 1,300 |
Twist Bioscience | 919 |
GoodRx Holdings | 694 |
ADMA Biologics | 624 |
TG Therapeutics | 264 |
Xenon Pharmaceuticals | 259 |
AMED News
- 3 months ago - Amedisys Reports First Quarter 2024 Financial Results - GlobeNewsWire
- 4 months ago - Oregon's health authority reviewing UnitedHealth's acquisition of Amedisys - Reuters
- 5 months ago - Amedisys Reports Fourth Quarter and Year-End 2023 Financial Results - GlobeNewsWire
- 5 months ago - Amedisys Offers Molecular Testing for Rapid and Accurate Infection Diagnosis - GlobeNewsWire
- 9 months ago - Amedisys Reports Third Quarter 2023 Financial Results - GlobeNewsWire
- 9 months ago - Amedisys Celebrates National Quality Week - GlobeNewsWire
- 11 months ago - Amedisys Recognizes Suicide Prevention Awareness Month and Promotes the 988 Suicide & Crisis Lifeline - GlobeNewsWire
- 1 year ago - Amedisys Reports Second Quarter 2023 Financial Results - GlobeNewsWire